|
시장보고서
상품코드
2088973
장기 간병용 기기 시장 : 제품 분류, 제품 유형, 기술, 용도, 최종 사용자, 유통 채널별 예측(2026-2032년)Long Term Care Devices Market by Product Class, Product Type, Technology, Application, End Users, Distribution Channel - Global Forecast 2026-2032 |
||||||
360iResearch
장기 간병용 기기 시장은 2032년까지 연평균 복합 성장률(CAGR) 8.23%로 4,198억 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도 : 2025년 | 2,412억 9,000만 달러 |
| 추정 연도 : 2026년 | 2,605억 2,000만 달러 |
| 예측 연도 : 2032년 | 4,198억 달러 |
| CAGR(%) | 8.23% |
장기 간병용 기기 시장 개요
의료 제도에서 만성 질환 관리, 재활, 이동 지원, 복약 관리, 안전 모니터링 등이 요양 시설, 요양형 주거 시설, 호스피스, 재택 간호로 전환됨에 따라 장기 간병용 기기 시장은 확대되고 있습니다. 이러한 수요는 명확한 인구 통계학적 요인에 의해 뒷받침되고 있습니다. 세계보건기구(WHO)의 보고에 따르면, 2030년까지 전 세계 인구의 6명 중 1명이 60세 이상이 될 것으로 예상되며, 유엔은 65세 이상 인구가 금세기 중반까지 계속 증가할 것으로 전망하고 있습니다.
장기 간병용 기기 분야의 혁신적인 변화
고령화, 노동력 부족, 가치 중심의 돌봄, 그리고 급성기 병원 외에서의 의료 제공으로의 전환이 맞물리면서 장기 간병용 기기의 현황은 재편되고 있습니다. 의료 제공업체들은 도입이 용이하고, 원격 모니터링을 지원하며, 피할 수 있는 응급실 이송을 줄일 수 있는 기기를 우선적으로 선택하고 있습니다.
장기 간병용 기기에 대한 인공지능의 누적 영향
인공지능(AI)은 낙상 위험 감지, 욕창 예방, 복약 순응도 관리, 생체 징후 모니터링, 호흡 상태 악화 경보 및 예측 유지보수를 개선함으로써 장기 간병용 의료기기 전반에 걸쳐 점차 누적 영향력을 발휘하고 있습니다. FDA의 공개 기록에 따르면, 의료 분야 전반에서 AI 및 머신러닝을 활용한 의료기기의 승인이 급속히 증가하고 있으며, 이는 검증된 알고리즘에 대한 규제 당국의 수용이 확대되고 있음을 반영하고 있습니다.
장기 간병용 기기에 관한 주요 지역별 인사이트
아시아태평양은 일본, 중국, 한국, 호주, 싱가포르가 급속한 인구 고령화와 재택치료 기술에 대한 수요 증가에 직면해 있어, 장기 간병용 기기 시장의 주요 성장 지역으로 부상하고 있습니다. 일본은 세계에서도 손꼽히는 고령 사회로서, 고령자용 로봇, 이동 지원, 커넥티드 모니터링 분야에서 계속해서 벤치마크 역할을 하고 있습니다. 한편, 중국과 인도에서는 만성 질환의 부담이 증가하고, 재택 간호가 보급되며, 장기 요양 인프라가 확대됨에 따라 시장 규모가 커질 것으로 전망됩니다.
세계 경제·정책 블록 내 주요 그룹별 인사이트
아세안 시장은 민간 병원 그룹, 의료 관광 거점, 그리고 특히 싱가포르, 태국, 말레이시아, 인도네시아, 베트남에서 노인 돌봄의 현대화를 지원하는 정부의 이니셔티브을 통해 확대되고 있습니다. GCC 국가들은 국가 차원의 의료 개혁 계획의 일환으로 디지털 헬스, 재택 간호, 재활, 그리고 첨단 의료 인프라에 투자하고 있으며, 이로 인해 고급 커넥티드 기기, 이동 지원, 모니터링 플랫폼, 호흡 지원 시스템에 대한 수요가 발생하고 있습니다.
장기 간병용 기기 수요에 관한 주요 국가 분석
미국은 높은 의료비 지출, 대규모 요양 시설 및 재택치료 생태계, 메디케어 및 메디케이드 급여 체계, 그리고 원격 환자 모니터링의 보급이 확대되고 있는 점 등으로 인해, 장기 간병용 기기 시장에 있어 여전히 주요 시장으로 자리 잡고 있습니다. 캐나다는 공공 자금을 통한 의료 서비스 접근성, 각 주의 ‘익숙한 곳에서 노후를 보내기’ 전략, 그리고 보조 기술을 중시하고 있습니다. 한편, 멕시코와 브라질에서는 민간 의료 서비스에 대한 접근성이 확대됨에 따라, 합리적인 가격의 이동 보조 기구, 가정용 호흡기, 재활 기기, 상처 관리 제품 및 만성 질환 관리 모니터링에 대한 수요가 증가하고 있습니다.
장기 간병용 기기 분야의 선도 기업을 위한 실천적 제안
업계 선도 기업들은 낙상, 욕창, 투약 오류, 호흡 기능 악화, 기능 저하 및 예방 가능한 입원을 줄여주는 임상적으로 검증된 장비를 우선적으로 도입해야 합니다. 제품 로드맵에서는 전자의무기록, 원격 모니터링 플랫폼, 간호사 호출 시스템, 약품 관리 도구 및 케어 조정 소프트웨어와의 상호 운용성을 중시해야 합니다.
증거에 기반한 시장 분석을 위한 조사 기법
본 요약본은 세계보건기구(WHO), 유엔 인구 데이터 세트, OECD 건강 지표, FDA 의료기기 관련 자료, CMS의 장기 요양 및 메디케어 정보, 유럽의 규제 체계, 각국의 의료 정책에 관한 간행물 등 권위 있는 공개 정보원을 바탕으로 한 2차 조사에 근거하고 있습니다. 이러한 인사이트은 인구 동향, 만성 질환 지표, 의료 서비스 제공 모델, 보험 지급 동향, 기술 도입 현황, 조달 기준 및 규제 요건을 종합적으로 분석하여 도출되었습니다.
결론: 장기 간병용 기기 시장의 향후 방향성
장기 간병용 기기 시장은 단일 기기에서 네트워크화되고 데이터를 활용한 케어 생태계로 전환되고 있습니다. 인구 고령화, 만성 질환 유병률 증가, 노동력 부족, 간병인의 부담, 그리고 병원 이용 감축에 대한 압력으로 인해, 시설 및 재택 간호 모두에서 지속적인 수요가 발생하고 있습니다.
자주 묻는 질문
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 AI의 누적 영향, 2026년
제7장 장기 간병용 기기 시장 : 제품 분류별
제8장 장기 간병용 기기 시장 : 제품 유형별
제9장 장기 간병용 기기 시장 : 기술별
제10장 장기 간병용 기기 시장 : 용도별
제11장 장기 간병용 기기 시장 : 최종 사용자별
제12장 장기 간병용 기기 시장 : 유통 채널별
제13장 장기 간병용 기기 시장 : 지역별
제14장 장기 간병용 기기 시장 : 그룹별
제15장 장기 간병용 기기 시장 : 국가별
제16장 경쟁 구도
제17장 기업 개요
JHSThe Long Term Care Devices Market is projected to grow by USD 419.80 billion at a CAGR of 8.23% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 241.29 billion |
| Estimated Year [2026] | USD 260.52 billion |
| Forecast Year [2032] | USD 419.80 billion |
| CAGR (%) | 8.23% |
Long Term Care Devices Market Overview
The long term care devices market is expanding as health systems shift more chronic disease management, rehabilitation, mobility support, medication management, and safety monitoring into nursing facilities, assisted living communities, hospice settings, and home-based care. Demand is supported by measurable demographic pressure: the World Health Organization reports that by 2030, one in six people worldwide will be aged 60 years or older, while the United Nations projects the population aged 65 and above will continue rising through mid-century.
For device manufacturers, this creates sustained demand for durable medical equipment, patient monitoring devices, mobility aids, pressure injury prevention systems, respiratory support products, infusion and enteral feeding devices, fall detection solutions, and connected care platforms. Competitive advantage is increasingly tied to clinical reliability, interoperability, reimbursement alignment, cybersecurity, and evidence showing reduced hospital readmissions, fewer adverse events, and improved caregiver productivity.
Transformative Shifts in the Long Term Care Device Landscape
The long term care devices landscape is being reshaped by the convergence of aging populations, workforce shortages, value-based care, and the movement of healthcare delivery outside acute-care hospitals. Providers are prioritizing devices that are easy to deploy, support remote supervision, and reduce avoidable transfers to emergency departments.
Manufacturers are also seeing procurement criteria evolve from product cost to total cost of care. Buyers increasingly evaluate battery life, serviceability, data integration, infection prevention, user training needs, and compatibility with electronic health records. This shift favors organizations that combine regulated hardware with software, analytics, maintenance services, and outcome-based support models.
Cumulative Impact of Artificial Intelligence on Long Term Care Devices
Artificial intelligence is becoming a cumulative force across long term care devices by improving fall risk detection, pressure ulcer prevention, medication adherence, vital sign monitoring, respiratory deterioration alerts, and predictive maintenance. FDA public records show rapid growth in AI and machine learning-enabled medical device authorizations across healthcare, reflecting broader regulatory acceptance of validated algorithms.
In long term care, the highest-value AI applications are those that reduce alarm fatigue, prioritize caregiver attention, and support earlier intervention without replacing clinical judgment. Manufacturers must design AI-enabled devices with explainability, bias testing, cybersecurity, privacy controls, and post-market performance monitoring to meet expectations from regulators, providers, residents, and families.
Key Regional Insights for Long Term Care Devices
Asia-Pacific is a major growth region for long term care devices because Japan, China, South Korea, Australia, and Singapore face rapid population aging and rising demand for home healthcare technologies. Japan remains a benchmark for eldercare robotics, mobility assistance, and connected monitoring as one of the world's most aged societies, while China and India offer scale as chronic disease burdens increase, home care adoption rises, and long term care infrastructure expands.
North America leads in reimbursement-enabled remote patient monitoring, durable medical equipment adoption, and technology-enabled senior care, supported by Medicare and Medicaid programs in the United States and publicly funded provincial healthcare systems in Canada. Latin America is advancing through private healthcare networks, urban long term care capacity, and chronic disease management needs, with Brazil and Mexico presenting demand for cost-effective mobility, monitoring, wound care, and respiratory devices.
Europe benefits from mature regulatory pathways, strong public healthcare systems, and policy focus on aging in place, while the Middle East is investing in hospital-to-home care, digital health, rehabilitation, and premium eldercare infrastructure across GCC markets. Africa remains earlier in adoption but presents long-term opportunity as noncommunicable diseases rise, urban healthcare capacity develops, and mobile health infrastructure improves access to basic monitoring and assistive devices.
Key Group Insights Across Global Economic and Policy Blocs
ASEAN markets are expanding through private hospital groups, medical tourism hubs, and government initiatives that support elderly care modernization, particularly in Singapore, Thailand, Malaysia, Indonesia, and Vietnam. GCC countries are investing in digital health, home care, rehabilitation, and advanced medical infrastructure as part of national health transformation plans, creating demand for premium connected devices, mobility support, monitoring platforms, and respiratory support systems.
The European Union offers a large, regulated market shaped by the Medical Device Regulation, data protection rules, and public procurement standards that reward clinical evidence, safety, and interoperability. BRICS economies combine large populations with expanding healthcare access, making affordability, localized manufacturing, and scalable distribution essential for long term care device adoption. G7 markets drive innovation in AI-enabled monitoring, rehabilitation technologies, connected durable medical equipment, and home-based care models, while NATO countries emphasize supply chain resilience, cybersecurity, emergency preparedness, and continuity of care for aging civilian and veteran populations.
Key Country Insights for Long Term Care Device Demand
The United States remains a central opportunity for long term care devices due to high healthcare spending, a large nursing facility and home health ecosystem, Medicare and Medicaid coverage structures, and strong remote patient monitoring adoption. Canada emphasizes publicly funded care access, provincial aging-in-place strategies, and assistive technologies, while Mexico and Brazil show rising demand for affordable mobility aids, home respiratory devices, rehabilitation equipment, wound care products, and chronic care monitoring supported by expanding private healthcare access.
In Europe, the United Kingdom is prioritizing community-based care, virtual wards, and digital social care records; Germany benefits from a large aging population, statutory long term care insurance, and a strong medical device base; and France supports home hospitalization and long term care modernization. Italy and Spain face among the highest old-age dependency pressures in Europe, increasing demand for mobility, fall prevention, pressure injury prevention, and home care devices, while Russia continues to show demand for rehabilitation, mobility, and chronic disease management devices despite procurement and geopolitical complexity.
In Asia-Pacific, China is scaling eldercare infrastructure and connected care pilots, India is emerging through home healthcare growth and chronic disease demand, and Japan leads in super-aged society solutions, including assistive robotics, smart beds, and remote monitoring. Australia supports aged care quality reforms, home-based care, and assistive technologies, while South Korea is advancing digital health, robotics, telemonitoring, and connected monitoring for older adults through a technologically mature healthcare environment.
Actionable Recommendations for Long Term Care Device Leaders
Industry leaders should prioritize clinically validated devices that reduce falls, pressure injuries, medication errors, respiratory deterioration, functional decline, and avoidable hospital transfers. Product roadmaps should emphasize interoperability with electronic health records, remote monitoring platforms, nurse call systems, pharmacy management tools, and care coordination software.
Manufacturers should invest in human-centered design for older adults and caregivers, including simplified interfaces, durable construction, infection-control features, multilingual instructions, ergonomic handling, and low-maintenance operation. Commercial strategies should combine reimbursement intelligence, health economic evidence, cybersecurity readiness, service models, and regional regulatory planning to accelerate adoption across nursing homes, assisted living, rehabilitation facilities, hospice care, and home care.
Research Methodology for Evidence-Based Market Analysis
This executive summary is based on secondary research from authoritative public sources, including the World Health Organization, United Nations population datasets, OECD health indicators, FDA medical device resources, CMS long term care and Medicare information, European regulatory frameworks, and national health policy publications. Insights were triangulated across demographic trends, chronic disease indicators, care delivery models, reimbursement dynamics, technology adoption, procurement criteria, and regulatory requirements.
Market interpretation follows a structured approach that evaluates device categories, end users, regional healthcare infrastructure, procurement behavior, adoption barriers, and technology readiness. The analysis emphasizes verified indicators and avoids unsupported projections, enabling decision-makers to assess long term care device opportunities with a practical, evidence-based perspective.
Conclusion: Future Direction of the Long Term Care Devices Market
The long term care devices market is moving from standalone equipment toward connected, data-enabled care ecosystems. Aging demographics, chronic disease prevalence, workforce constraints, caregiver burden, and pressure to reduce hospital utilization are creating durable demand across institutional and home-based care settings.
Manufacturers that combine reliable hardware, validated software, regulatory discipline, cybersecurity, affordability, and measurable care outcomes will be best positioned to support evolving provider needs. The next phase of competition will be defined by interoperability, AI-enabled decision support, inclusive design, service reliability, and the ability to prove value across diverse regional care models.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.1.1. Aging Populations Convert Long-Term Care Devices into Essential Care Infrastructure
- 4.3.1.2. Hospital-to-Home Care Migration Expands Demand Beyond Institutional Facilities
- 4.3.1.3. Chronic Disease Management Creates Recurring Device and Data Demand
- 4.3.1.4. Care Workforce Shortages Accelerate Automation and Safety Investments
- 4.3.2. Key Restraints
- 4.3.2.1. Uneven Reimbursement and Budget Pressure Limit Premium Device Adoption
- 4.3.2.2. Rising Compliance Complexity Increases Cost and Time-to-Market
- 4.3.3. Key Opportunities
- 4.3.3.1. AI-Enabled Fall Prevention Can Create a High-Value Safety Platform
- 4.3.3.2. Connected Respiratory Care Unlocks Device, Consumable, and Software Revenue
- 4.3.3.3. Skin Integrity Platforms Can Link Prevention, Treatment, and Documentation
- 4.3.4. Key Challenges
- 4.3.4.1. Interoperability Gaps Limit the Value of Connected Long-Term Care Workflows
- 4.3.4.2. Geopolitical Supply Volatility Raises Lead-Time and Margin Risk
- 4.3.1. Key Drivers
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Long Term Care Devices Market, by Product Class
- 7.1. Mobility & Transfer Equipment
- 7.1.1. Wheelchairs
- 7.1.1.1. Manual
- 7.1.1.2. Powered
- 7.1.2. Walkers & Ambulation Aids
- 7.1.3. Lifts & Transfer Systems
- 7.1.4. Beds & Positioning Frames
- 7.1.5. Mobility Scooters
- 7.1.1. Wheelchairs
- 7.2. Patient Monitoring & Safety Equipment
- 7.2.1. Vital Signs Monitoring
- 7.2.1.1. Blood Pressure Monitors
- 7.2.1.2. Pulse Oximeters
- 7.2.1.3. Thermometers
- 7.2.1.4. Glucose Monitors
- 7.2.2. Fall Detection & Prevention
- 7.2.2.1. Wearable Fall Detectors
- 7.2.2.2. Alarms
- 7.2.2.3. Motion Sensors
- 7.2.3. Nurse Call & Alerting
- 7.2.3.1. Wired Call Systems
- 7.2.3.2. Wireless Pendants
- 7.2.1. Vital Signs Monitoring
- 7.3. Respiratory & Sleep Support Equipment
- 7.3.1. Oxygen Therapy
- 7.3.2. Ventilatory Support
- 7.3.3. Airway Clearance & Aerosol Delivery
- 7.3.4. Sleep Diagnostics & Management
- 7.4. Therapeutic Support & Skin Integrity Equipment
- 7.4.1. Seating & Positioning Systems
- 7.4.2. Wound Therapy Equipment
- 7.4.2.1. Negative Pressure Wound Therapy Systems
- 7.4.2.2. Wound Measurement Devices
- 7.4.2.3. Light Therapy Devices
- 7.5. Continence & Toileting Equipment
- 7.6. Medication & Nutrition Management Equipment
- 7.6.1. Medication Dispensers
- 7.6.2. Smart Cabinets
- 7.7. Communication & Cognitive Support Equipment
8. Long Term Care Devices Market, by Product Type
- 8.1. Non-Wearable Devices
- 8.2. Wearable Devices
9. Long Term Care Devices Market, by Technology
- 9.1. Manual Devices
- 9.2. Electrically Powered Devices
- 9.3. Smart/Connected Devices
- 9.3.1. IoT-Enabled Devices
- 9.3.2. AI-Integrated Devices
10. Long Term Care Devices Market, by Application
- 10.1. Elderly Care
- 10.2. Chronic Disease Management
- 10.2.1. Diabetes
- 10.2.2. Cardiovascular Diseases
- 10.2.3. Respiratory Disorders
- 10.3. Post-Surgical Care
- 10.4. Disability Support
- 10.4.1. Temporary
- 10.4.2. Permanent
11. Long Term Care Devices Market, by End Users
- 11.1. Assisted Living Facilities
- 11.2. Home Care Settings
- 11.3. Hospices & Nursing Homes
- 11.4. Hospitals
- 11.5. Rehabilitation Centers
12. Long Term Care Devices Market, by Distribution Channel
- 12.1. Offline
- 12.2. Online
13. Long Term Care Devices Market, by Region
- 13.1. Asia-Pacific
- 13.2. North America
- 13.3. Latin America
- 13.4. Europe
- 13.5. Middle East
- 13.6. Africa
14. Long Term Care Devices Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
15. Long Term Care Devices Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
16. Competitive Landscape
- 16.1. Market Concentration Analysis, 2025
- 16.1.1. Concentration Ratio (CR)
- 16.1.2. Herfindahl Hirschman Index (HHI)
- 16.2. Recent Developments & Impact Analysis, 2025
- 16.3. Product Portfolio Analysis, 2025
- 16.4. Benchmarking Analysis, 2025
17. Company Profiles
- 17.1. Baxter International Inc.
- 17.2. Abbott Laboratories
- 17.3. Medline Industries, LP
- 17.4. Fresenius Medical Care AG
- 17.5. ResMed Inc.
- 17.6. Coloplast A/S
- 17.7. B. Braun SE
- 17.8. Medtronic PLC
- 17.9. Invacare Holdings Corporation
- 17.10. Stryker Corporation
- 17.11. Solventum
- 17.12. Cardinal Health, Inc.
- 17.13. Convatec Group Plc
- 17.14. Koninklijke Philips N.V.
- 17.15. Becton, Dickinson and Company
- 17.16. ICU Medical, Inc.
- 17.17. F. Hoffmann-La Roche Ltd.
- 17.18. Linde PLC
- 17.19. Asahi Kasei Corporation
- 17.20. Omron Corporation
- 17.21. Drive DeVilbiss Healthcare
- 17.22. Savaria Corporation
- 17.23. ARKRAY Inc.
- 17.24. GE HealthCare Technologies Inc.
- 17.25. BMC Medical Co., Ltd.
- 17.26. Boston Scientic Corporation
- 17.27. Breas Medical AB
- 17.28. CAIRE Inc.
- 17.29. Compass Health Brands
- 17.30. Getinge AB
- 17.31. GF Health Products, Inc.
- 17.32. Honeywell International Inc.
- 17.33. Joerns Healthcare
- 17.34. Johnson & Johnson Services Inc.
- 17.35. PHC Holdings Corporation
- 17.36. React Health Holdings, LLC
- 17.37. Siemens Healthineers AG
- 17.38. Sunrise Medical LLC
- 17.39. Vayyar Care
